Compare BLD & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLD | RVMD |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 19.1B |
| IPO Year | 2015 | N/A |
| Metric | BLD | RVMD |
|---|---|---|
| Price | $347.99 | $92.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | ★ $439.57 | $117.33 |
| AVG Volume (30 Days) | 343.1K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.28 | N/A |
| Revenue | ★ $2,384,249,000.00 | N/A |
| Revenue This Year | $13.44 | N/A |
| Revenue Next Year | $4.30 | $408.69 |
| P/E Ratio | $19.00 | ★ N/A |
| Revenue Growth | ★ 25.07 | N/A |
| 52 Week Low | $272.24 | $29.17 |
| 52 Week High | $559.47 | $124.49 |
| Indicator | BLD | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 37.53 |
| Support Level | $331.33 | $74.64 |
| Resistance Level | $445.50 | $107.45 |
| Average True Range (ATR) | 13.56 | 3.22 |
| MACD | 1.05 | -0.56 |
| Stochastic Oscillator | 26.58 | 5.81 |
TopBuild Corp is an installer and distributor of insulation products. Its operating segments are: Installation Services and Specialty Distribution. The Installation Services segment, which generates maximum revenue, installs insulation, commercial roofing, and other building products like glass and windows, rain gutters, doors, etc, mainly in the residential new construction market. The Specialty Distribution segment distributes building and mechanical insulation, insulation accessories, and other building product materials for the residential, commercial, and industrial markets. In addition to insulation and accessories, it distributes rain gutters, closet shelving, roofing materials, and other items. Geographically, the firm mainly operates in the U.S. and, to a lesser extent, in Canada.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.